Goode Named President, CEO of Unimed Pharmaceuticals

The board of directors of Unimed Pharmaceuticals, Inc. (Buffalo Grove, Ill.) has announced the appointment of Ronald L. Goode, Ph.D., to the position of president and chief executive officer and director. For more than 11 years, Goode has served in various positions of increasing responsibility at G.D. Searle & Co., most recently as corporate senior vice president and president, Asia/Pacific World Area.

Goode began his pharmaceutical career at Hoffmann-La Roche, subsequently moving to Pfizer for 10 years before initiating his tenure at Searle. In addition to general management, Goode's prior experience included responsibility for business development, licensing, marketing research and planning, and product development.

Commenting on his appointment, Goode said, "Unimed has a proud history and a stable portfolio of established products marketed using a successful niche strategy. With its exceptionally strong balance sheet, Unimed is perfectly positioned to leap to the next level in the pharmaceutical industry."

Goode holds a doctorate in microbial genetics from the University of Georgia, a master's degree in microbiology from the University of Memphis, and an undergraduate degree in biology from that same institution.

Unimed Pharmaceuticals, Inc. develops and markets niche pharmaceutical products for AIDS, oncology, endocrinology, urology and infectious disease therapeutic areas.